Arbor Biotechnologies

About Arbor Biotechnologies

Arbor Biotechnologies is focused on developing novel gene editing treatments for people living with genetic diseases. The company aims to revolutionize disease treatment through next-generation gene editing technologies, with a mission to deliver functional cures and enable curative treatments for patients worldwide.

Products & Services

Next-Generation Gene Editing:A diverse toolbox of novel gene editors enabling therapeutic applications across a broad range of diseases.

Pipeline of Genetic Medicines:Lead indications targeting liver and CNS diseases, with a strategy to deliver on the promise of genetic medicines for more patients.

Specialties

Gene Editing Genetic Medicines Therapeutic Applications for Genetic Diseases Liver and CNS Disease Focus

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 73900000 MR: - FA: $73.9 million FAN: 73900000	D: 2025-03-18 FD: 2025-03-18	15 investors

Series C Latest

2025-03-18

$73.9M

15 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

N

Nicole Saras

M

Malini Varadarajan

G

Gillian Mehigan

T

Tara Naylor

A

Amy Biasella

J

Jared Shapiro

View 113 more team members with Pro

Unlock Full Team Directory

Recent News